Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBCBSTX Oral Cancer Testing Policy Update | OpenPay…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - TexasPolicy RPLAB032

    Oral Cancer Screening and Testing

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Texas Policy RPLAB032 alerts

    Get alerted when Policy RPLAB032 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This reimbursement policy establishes lab management criteria for oral cancer screening, diagnostic testing, and HPV tumor-status testing. It applies to providers submitting claims to Blue Cross Blue Shield of Texas, subject to applicable plan documents and provider contracts.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyOral Cancer Screening and Testing
    Policy CodePolicy RPLAB032
    Change TypePolicy clarification and code updates
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionDo not expect reimbursement for noninvasive oral cancer screening, detection, or diagnostic tests.
    SourceLink
    POLICY UPDATE CHANGES

    The policy clarified that mRNA CancerDetect and the OmniPathology Oropharyngeal HPV PCR Test are never reimbursable when used to screen for, detect, or diagnose oral cancer.

    Procedure code 0296U was added to the policy's listed procedure codes.

    Procedure codes 81599, 82397, 88341, and 88342 were removed from the policy's listed procedure codes.

    2Testing situations in which high-risk HPV testing may be reimbursable
    3Categories of oral cancer testing identified as not reimbursable

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    5
    Procedure codes listed in the policy
    4Procedure codes removed in the latest documented update

    Oral Cancer and HPV Testing Coverage

    Potentially reimbursable HPV tumor-status testing

    Testing may be reimbursable when used to establish HPV tumor status in specified clinical situations.

    ALL of the following

    • ONE of

      • Individual has oropharyngeal squamous cell carcinoma
      • Individual has metastatic squamous cell carcinoma of unknown primary origin in a cervical lymph node
    • Testing uses high-risk HPV mRNA expression testing for HPV E6/E7 or immunohistochemistry

    Nonreimbursable oral cancer screening and diagnostic testing

    The following testing is not reimbursable when used to screen for, detect, or diagnose oral cancer.

    ANY of the following

    • Noninvasive oral cancer screening, detection, or diagnostic testing, including mRNA CancerDetect™
    • OmniPathology Oropharyngeal HPV PCR Test
    • Salivary biomarker testing involving peptides, proteins, nucleic acids, or metabolites
    • A panel incorporating genetic risk factors with nongenetic biomarkers
    • Detection of HPV from an oropharyngeal swab

    Procedure Codes

    HPV testing codesCPT
    87624HPV high-risk type, pooled result
    87625HPV types 16 and 18 only
    87626HPV separate high-risk typing and pooled result
    Oral and oropharyngeal cancer molecular testingCPT
    0296UOncology oral and/or oropharyngeal cancer, 20 molecular features
    Oropharyngeal HPV swab testingCPTNot Covered
    0429UHPV oropharyngeal swab, 14 high-risk types

    Provider and Billing Requirements

    Documentation Required

    Documentation Submission

    Submit accurate documentation of the services performed and provide any additional documentation requested by BCBSTX.

    Billing Rule

    Accurate Claim Coding

    Submit claims using valid code combinations from HIPAA-approved code sets and code services according to applicable industry-standard coding guidelines.

    • Uniform Billing Editor
    • American Medical Association Current Procedural Terminology (CPT) Assistant
    • Healthcare Common Procedure Coding System
    • ICD-10-CM and ICD-10-PCS
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyOral Cancer Screening and Testing
    Policy CodePolicy RPLAB032
    Change TypePolicy clarification and code updates
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionDo not expect reimbursement for noninvasive oral cancer screening, detection, or diagnostic tests.
    SourceLink
    On This Page
    Oral Cancer and HPV Testing CoverageProcedure CodesProvider and Billing Requirements
  1. National Drug Codes
  2. Diagnosis Related Group guidelines
  3. CMS National Correct Coding Initiative Policy Manual, CCI table edits, and other CMS guidelines
  4. Billing Rule

    Claim Review and Code Edits

    Before submitting a claim, review applicable benefit coverage terms, provider contract language, medical and reimbursement policies, and coding software logic. Claims are subject to code-edit protocols and claim review.

    Note

    Product-Specific Requirements

    Review the applicable Plan documents before rendering and billing services because reimbursement requirements may vary by product. If a conflict exists, the applicable Plan document or provider contract governs.

    • Eligible coverage requirements are not the same for every product.
    Note

    Potentially Reimbursable HPV Tumor-Status Testing

    High-risk HPV testing may be reimbursable to establish HPV tumor status in qualifying patients with oropharyngeal squamous cell carcinoma or metastatic squamous cell carcinoma of unknown primary origin in a cervical lymph node.

    • MRNA expression testing for HPV E6/E7
    • Immunohistochemistry
    Denial Risk

    Nonreimbursable Oral Cancer Testing

    Noninvasive tests designed to screen for, detect, or diagnose oral cancer are not reimbursable, including the examples and testing categories below.

    • mRNA CancerDetect™
    • OmniPathology Oropharyngeal HPV PCR Test
    • Salivary biomarker testing, including peptides/proteins, nucleic acids, or metabolites
    • Panels incorporating genetic risk factors with nongenetic biomarkers
    • Detection of HPV from an oropharyngeal swab